Education
About Us
Working with TipRanks
Follow Us
Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -222.00 | $ -27.53M | $ -12.13M | $ -15.14M |
| Operating Income | $ -12.05M | $ -11.46M | $ -27.53M | $ -12.13M | $ -15.14M |
| EBITDA | $ -11.85M | $ -11.46M | $ -19.47M | $ -11.08M | $ -5.63M |
| Net Income | $ -11.85M | $ -11.12M | $ -54.85M | $ -11.43M | $ -14.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.19M | $ 4.71M | $ 6.50M | $ 16.50M | $ 15.42M |
| Total Assets | $ 3.23M | $ 5.79M | $ 8.62M | $ 26.46M | $ 25.21M |
| Total Debt | $ 73.51K | $ 150.55K | $ 229.45K | $ 78.46K | $ 328.12K |
| Net Debt | $ -1.12M | $ -4.56M | $ -6.27M | $ -16.42M | $ -15.09M |
| Total Liabilities | $ 1.53M | $ 797.48K | $ 1.15M | $ 978.40K | $ 2.27M |
| Stockholders' Equity | $ 1.70M | $ 4.99M | $ 7.47M | $ 25.49M | $ 22.94M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.25M | $ -8.07M | $ -9.61M | $ -8.72M | $ -3.14M |
| Operating Cash Flow | $ -11.25M | $ -8.06M | $ -9.61M | $ -8.72M | $ -3.14M |
| Investing Cash Flow | $ -3.24K | $ -2.78K | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 7.73M | $ 6.27M | $ -388.84K | $ 9.80M | $ 17.87M |